JESSICA FULK: Open Payments
NPI 1467946277 · DENVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 8 payments from 7 companies in 2025. Trend: 2023 $1,751 · 2024 $1,140 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Genmab U.S., Inc. | 1 | $26 |
| Fennec Pharmaceuticals, Inc. | 1 | $24 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| ACCORD HEALTHCARE, INC. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
Products named: INGREZZA, Epkinly, Fyarro, LORBRENA, ELREXFIO, Hercessi, Enhertu.
Industry payments across NC — which companies pay providers there.
